Journal
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
Volume 55, Issue 5, Pages 315-324Publisher
BRITISH MED JOURNAL PUBL GROUP
DOI: 10.1136/mp.55.5.315
Keywords
-
Categories
Ask authors/readers for more resources
Background: Two mouse monoclonal antibodies have been described, namely: mAb 2C7 (IgG2bkappa), which is directed against the major house dust mite allergen Der p 1, and mAb 2G10 (IgG 1 kappa), which is an anti-idiotypic antibody raised against mAb 2C7. Given its broad IgE specificity, anti-idiotype mAb 2G 10 could potentially have immunomodulatory applications. For example, a chimaeric human IgG version of mAb 2G 10 could prove to be a useful molecule for binding to mast cell and basophil FcepsilonRI bound IgE, and in doing so co-ligating FcepsilonRI with FcgammaRIIB, which has been reported to have downregulatory effects. Aims: To produce a chimaeric human IgE version of mAb 2C7 (mAb 2C7huE) and a chimaeric human IgG1 version of its anti-idiotype mAb 2G 10 (mAb 2G 10huG1). Methods: The Vkappa and VH regions of mAb 2C7 and its anti-idiotype mAb 2G 10 were engineered into human constant regions of the IgE and IgG1 isotypes, respectively. Results: The production of chimaeric mAb 2C7huE and its anti-idiotype mAb 2G10huG1 confirmed that the respective mouse antibody V regions were successfully engineered into human constant regions and still retained the specificity of the original murine V regions. Conclusion:The newly constructed chimaeric antibodies will be useful to investigate the downregulation of IgE mediated hypersensitivity by the crosslinking of FcepsilonRI with FcgammaRIlB.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available